Metabolic analyses on both stem cell-enriched (CD34+ and CD34+CD38-) and differentiated (CD34-) cells derived from individuals with CML indicate that primitive CML cells rely on upregulated oxidative metabolism for their survival [178]. The gene discussed is CD38; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.